Our top pick for
Building a portfolio
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Akers Biosciences stock
Own Akers Biosciences stock in just a few minutes.
Akers Biosciences, Inc is a medical instruments & supplies business based in the US. Akers Biosciences shares (AKER) are listed on the NASDAQ and all prices are listed in US Dollars. Akers Biosciences employs 4 staff and has a trailing 12-month revenue of around USD0.00.
How to buy shares in Akers Biosciences
- Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
- Search for Akers Biosciences. Find the stock by name or ticker symbol: AKER. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Akers Biosciences reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Akers Biosciences, depending on your broker.
- Check in on your investment. Congratulations, you own a part of Akers Biosciences. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
What's in this guide?
Akers Biosciences share price
Use our graph to track the performance of AKER stocks over time.Akers Biosciences shares at a glance
Information last updated 2021-04-15.
| 52-week range | USD$1.65 - USD$6.97 |
|---|---|
| 50-day moving average | USD$3.2509 |
| 200-day moving average | USD$2.5922 |
| Wall St. target price | USD$4 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | USD$-0.715 |
Buy Akers Biosciences shares from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Akers Biosciences stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Akers Biosciences financials
| Revenue TTM | USD$1.6 million |
|---|---|
| Gross profit TTM | USD$478,747 |
| Return on assets TTM | -32.18% |
| Return on equity TTM | -55.32% |
| Profit margin | 0% |
| Book value | $1.958 |
| Market capitalisation | USD$44 million |
TTM: trailing 12 months
Shorting Akers Biosciences shares
There are currently 1.6 million Akers Biosciences shares held short by investors – that's known as Akers Biosciences's "short interest". This figure is 16.5% down from 1.9 million last month.
There are a few different ways that this level of interest in shorting Akers Biosciences shares can be evaluated.
Akers Biosciences's "short interest ratio" (SIR)
Akers Biosciences's "short interest ratio" (SIR) is the quantity of Akers Biosciences shares currently shorted divided by the average quantity of Akers Biosciences shares traded daily (recently around 321659.8019802). Akers Biosciences's SIR currently stands at 5.05. In other words for every 100,000 Akers Biosciences shares traded daily on the market, roughly 5050 shares are currently held short.
However Akers Biosciences's short interest can also be evaluated against the total number of Akers Biosciences shares, or, against the total number of tradable Akers Biosciences shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Akers Biosciences's short interest could be expressed as 0.1% of the outstanding shares (for every 100,000 Akers Biosciences shares in existence, roughly 100 shares are currently held short) or 0.0975% of the tradable shares (for every 100,000 tradable Akers Biosciences shares, roughly 98 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Akers Biosciences.
Find out more about how you can short Akers Biosciences stock.
Akers Biosciences share dividends
We're not expecting Akers Biosciences to pay a dividend over the next 12 months.
Have Akers Biosciences's shares ever split?
Akers Biosciences's shares were split on a 1:24 basis on 24 November 2019. So if you had owned 24 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Akers Biosciences shares – just the quantity. However, indirectly, the new 2300% higher share price could have impacted the market appetite for Akers Biosciences shares which in turn could have impacted Akers Biosciences's share price.
Akers Biosciences share price volatility
Over the last 12 months, Akers Biosciences's shares have ranged in value from as little as $1.65 up to $6.97. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Akers Biosciences's is 0.3354. This would suggest that Akers Biosciences's shares are less volatile than average (for this exchange).
Akers Biosciences overview
Akers Biosciences, Inc. focuses on the development of a vaccine candidate against SARS-CoV-2, a coronavirus causing a pandemic. It has a collaboration agreement with Premas Biotech PVT Ltd. The company was incorporated in 1989 and is headquartered in New York, New York. .
Frequently asked questions
More guides on Finder
-
T. Rowe Price review
Features, fees and complaints to consider before you apply for a T. Rowe Price account.
-
How to buy ZTO Express Cayman stock
Steps to owning and managing ZTO, with 24-hour and historical pricing before you buy.
-
How to buy Zomedica stock
Steps to owning and managing ZOM, with 24-hour and historical pricing before you buy.
-
How to buy ZoomInfo Technologies stock
Steps to owning and managing ZI, with 24-hour and historical pricing before you buy.
-
How to buy ZK International Group CoLtd stock
Steps to owning and managing ZKIN, with 24-hour and historical pricing before you buy.
-
How to buy Zions Bancorporation National Association stock
Steps to owning and managing ZION, with 24-hour and historical pricing before you buy.
-
How to buy Zentalis Pharmaceuticals stock
Steps to owning and managing ZNTL, with 24-hour and historical pricing before you buy.
-
How to buy Yunhong International stock
Steps to owning and managing ZGYH, with 24-hour and historical pricing before you buy.
-
How to buy Zealand Pharma A/S stock
Steps to owning and managing ZEAL, with 24-hour and historical pricing before you buy.
-
How to buy Yunhong CTI stock
Steps to owning and managing CTIB, with 24-hour and historical pricing before you buy.
Ask an Expert